Company · Ownership research

AGIOS PHARMACEUTICALS, INC. AGIO

CIK 0001439222

Form 4 transactions dated Nov 1, 2023 to Nov 12, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 32 rows; the complete set is available through the API.

Insider filings on file run through Oct 28, 2026.

Insider purchases & sales

Purchased: $0.00
Sold: $19.35M

Nov 1, 2023 – Oct 28, 2026
Available records · partial months are marked ·

202510 of 30 preview events · 32 available in 2025

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 30, 2025	Burns James William Chief Legal Officer	Sale10b5-1 footnote	$79.43K 2,932 shares sold	8.46% sold Direct holding	▾
Dec 30, 2025	Goff Brian Chief Executive Officer · Director	Sale10b5-1 footnote	$506.66K 18,703 shares sold	Unavailable Direct holding	▾
Dec 30, 2025	Gheuens Sarah Chief Medical Officer	Sale10b5-1 footnote	$79.43K 2,932 shares sold	4.33% sold Direct holding	▾
Dec 30, 2025	Milanova Tsveta Chief Commercial Officer	Sale10b5-1 footnote	$79.43K 2,932 shares sold	9.13% sold Direct holding	▾
Dec 30, 2025	Jones Cecilia Chief Financial Officer	Sale10b5-1 footnote	$79.43K 2,932 shares sold	7.27% sold Direct holding	▾
Nov 12, 2025	Scadden David Director	Sale10b5-1 footnote	$8.77K 200 shares sold	1.12% sold Direct holding	▾
Nov 11, 2025	Gheuens Sarah Chief Medical Officer	Sale10b5-1 footnote	$107.44K 2,454 shares sold	3.82% sold Direct holding	▾
Oct 30, 2025	Gheuens Sarah Chief Medical Officer	Sale10b5-1 footnote	$8.76K 200 shares sold	0.32% sold Direct holding	▾
Oct 27, 2025	Gheuens Sarah Chief Medical Officer	Sale10b5-1 footnote	$145.02K 3,302 shares sold	5.08% sold Direct holding	▾
Oct 8, 2025	Scadden David Director	Sale10b5-1 footnote	$8.20K 200 shares sold	1.12% sold Direct holding	▾

Showing 30 / 32 record groups in 2025. The complete set is available through the API.

AGIOS PHARMACEUTICALS, INC. · AGIO

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 32 purchase / sale groups and 30 of 128 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"AGIO","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.